Tag:

Wegovy

NJ-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales NJ-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales
Nj-based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing illegal knockoff versions of its weight-loss drug Wegovy and deceptive marketing. The pharmaceutical giant with US headquarters in Plainsboro, New Jersey, announced the termination of its deal with Hims & Hers in a news release on Monday, June 23. Shares in Hims & Hers plummeted more than 26% when Wall Street began trading for the day. The move comes weeks after the Food and Drug Administration declared that the nationwide shortage of Wegovy was resolv…
What Happens When You Stop Taking Ozempic? Bergen County Docs Explain What Happens When You Stop Taking Ozempic? Bergen County Docs Explain
What Happens When You Stop Taking Ozempic? Bergen County Docs Explain So, you've been on Ozempic or Wegovy for some time.  You're seeing the desired results, and you're ready to come off.  Will you regain the weight? Will prior risk factors return? If so, how quickly? According to Dr. Hans Schmidt, the director of the Center for Weight Loss and Metabolic Health for Hackensack Meridian Health, coming off Ozempic is much like coming off a crash diet. "Once you take away whatever medication is working so well, most people will gain the weight back," Schmidt said. "Often more than they’ve lost." Ozempic is a GLP1, a naturally occurring molecule relea…
Hollywood's Weight Loss Ozempic Craze Explained By NJ Docs Hollywood's Weight Loss Ozempic Craze Explained By NJ Docs
Hollywood's Weight Loss Ozempic Craze Explained By NJ Docs A brand-name drug intended for treatment of patients with type 2 diabetes has become something of a magic medication for celebrities looking to slim down for summer. While the effects of Ozempic (Semaglutide) are nothing new to doctors like Colette Knight, Chair of Hackensack University Medical Center’s Diabetes Institute, the injectable drug seems to only recently have caught on in Hollywood. Doctor Colette Knight, Chair of Hackensack University Medical Center’s Diabetes Institute, and David Shaker (DO), who specializes in internal medicine at Holy Name Medical Center.Provided "We’ve kn…